Abstract
Twenty-five adult epileptic patients who had shown a satisfactory clinical response to add-on vigabatrin under placebo-controlled conditions continued on long-term treatment for up to 47 months (median 22 months). The initially favourable therapeutic response was generally maintained throughout the observation period with an overall good clinical tolerance. No evidence of neurotoxicity was detected by multimodal evoked potentials monitoring.
| Original language | English |
|---|---|
| Pages (from-to) | 467-471 |
| Number of pages | 5 |
| Journal | Journal of Neurology, Neurosurgery and Psychiatry |
| Volume | 52 |
| Issue number | 4 |
| Publication status | Published - 1989 |
Fingerprint
ASJC Scopus subject areas
- Psychiatry and Mental health
- Neuroscience(all)
- Neuropsychology and Physiological Psychology
Cite this
Vigabatrin in the treatment of epilepsy : A long-term follow-up study. / Tartara, A.; Manni, R.; Galimberti, C. A.; Mumford, J. P.; Iudice, A.; Perucca, E.
In: Journal of Neurology, Neurosurgery and Psychiatry, Vol. 52, No. 4, 1989, p. 467-471.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Vigabatrin in the treatment of epilepsy
T2 - A long-term follow-up study
AU - Tartara, A.
AU - Manni, R.
AU - Galimberti, C. A.
AU - Mumford, J. P.
AU - Iudice, A.
AU - Perucca, E.
PY - 1989
Y1 - 1989
N2 - Twenty-five adult epileptic patients who had shown a satisfactory clinical response to add-on vigabatrin under placebo-controlled conditions continued on long-term treatment for up to 47 months (median 22 months). The initially favourable therapeutic response was generally maintained throughout the observation period with an overall good clinical tolerance. No evidence of neurotoxicity was detected by multimodal evoked potentials monitoring.
AB - Twenty-five adult epileptic patients who had shown a satisfactory clinical response to add-on vigabatrin under placebo-controlled conditions continued on long-term treatment for up to 47 months (median 22 months). The initially favourable therapeutic response was generally maintained throughout the observation period with an overall good clinical tolerance. No evidence of neurotoxicity was detected by multimodal evoked potentials monitoring.
UR - http://www.scopus.com/inward/record.url?scp=0024562589&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024562589&partnerID=8YFLogxK
M3 - Article
C2 - 2661725
AN - SCOPUS:0024562589
VL - 52
SP - 467
EP - 471
JO - Journal of Neurology, Neurosurgery and Psychiatry
JF - Journal of Neurology, Neurosurgery and Psychiatry
SN - 0022-3050
IS - 4
ER -